Page last updated: 2024-10-26

dipyridamole and Pus

dipyridamole has been researched along with Pus in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gal'perin, EI1
Tatishvili, GG1
Akhaladze, GG1
Sakevarashvili, GR1
Nasirov, FN1
Aref'ev, AE1

Other Studies

1 other study available for dipyridamole and Pus

ArticleYear
[Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis].
    Khirurgiia, 1991, Issue:9

    Topics: Acute Disease; Animals; Aprotinin; Ascorbic Acid; Aspirin; Cholangitis; Cholestasis; Dextrans; Dipyr

1991